JACC Specialty Journals
Advances in a Capsule: October 2026 | JACC: Advances
Oct 29, 202610 min
Audio Summary of three articles from the October 2026 issue of JACC: Advances.
health
JACC Specialty Journals
Hosted by American College of Cardiology · health · EN
About this Podcast:
In this podcast series, editors-in-chief from the JACC family of specialty journals provide highlights and summarize key findings for select issues. Published by the American College of Cardiology, the JACC Journals publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, and review articles. They are top ranked for impact factor and their manuscripts are among the most covered by media outlets, most talked about on social media, and most read online.
Pitch Analysis
Required Pod Score for this podcast. PitchCentric checks your profile against host openness, topical fit, and audience signals before you generate a pitch.
Contact path
Verified email
Booking probability
40%
Guest openness
Selective
80/100
Required Score
Sign up to generate a grounded pitch for JACC Specialty Journals.
Signup to Generate a PitchQuestions about JACC Specialty Journals
What is JACC Specialty Journals about?
In this podcast series, editors-in-chief from the JACC family of specialty journals provide highlights and summarize key findings for select issues. Published by the American College of Cardiology, the JACC Journals publish peer-reviewed articles on all aspects of cardiovascular disease, including original clinical studies, translational investigations with clear clinical relevance, state-of-the art papers, and review articles.
What has JACC Specialty Journals covered recently?
Recent episodes include "Advances in a Capsule: October 2026 | JACC: Advances" (29 October 2026, 10 minutes), "XGBoost Model with CMR Features for Prognostic Assessment in Patients With ST‑Segment Elevation Myocardial Infarction | JACC: Asia" (20 October 2026, 5 minutes), and "Design and Rationale of GPS-CAD: Global Pretest Probability Study of Coronary Artery Disease | JACC: Asia" (20 October 2026, 4 minutes).
How often does JACC Specialty Journals publish?
JACC Specialty Journals publishes roughly daily, with episodes averaging 8 minutes across more than 1,000 episodes.
How hard is it to get booked on JACC Specialty Journals?
Booking probability for JACC Specialty Journals is 40%, and the host is rated Selective on guests. JACC Specialty Journals requires a Pod Score of 80 or higher. JACC Specialty Journals's contact route on record: verified email.
Who should pitch JACC Specialty Journals?
The strongest fits for JACC Specialty Journals are Doctors & Physicians and Scientific Research & Development. JACC Specialty Journals has a health audience.
About the host
JACC Specialty Journals is a health podcast with more than 1,000 episodes published.
Verified host email: ████████@████.comSign in to unlock →
Recent episodes
Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.
JACC Specialty Journals
XGBoost Model with CMR Features for Prognostic Assessment in Patients With ST‑Segment Elevation Myocardial Infarction | JACC: Asia
Oct 20, 20265 minCommentary by Dr. Yoriyasu Suzuki.
JACC Specialty Journals
Design and Rationale of GPS-CAD: Global Pretest Probability Study of Coronary Artery Disease | JACC: Asia
Oct 20, 20264 minCommentary by Dr. Junjie Yang.
JACC Specialty Journals
Prediction of Paroxysmal Atrial Fibrillation with Incorporating Genomic Information Into AI-Based ECG Analysis | JACC: Asia
Oct 20, 20263 minCommentary by Dr. Qinkai Yu.
JACC Specialty Journals
October 2026 Summary | JACC: CardioOncology
Oct 20, 20262 minEditor-in-Chief Dr. Bonnie Ky introduces the October 2026 issue of JACC: CardioOncology, featuring Part 1 of a special focus on immunology and cardio-oncology. This issue brings together state-of-the-art reviews...
View More
JACC Specialty Journals
Fibrotic Rewiring of CD8+ T-cells by Doxorubicin Drives Pathological Remodeling of Cardiac Extracellular Matrix | JACC: CardioOncology
Oct 20, 20263 minDr. Caitlin O'Meara discusses a JACC: CardioOncology study showing that doxorubicin reprograms CD8+ T cells into matrix-remodeling T cells (mxT-cells) that produce lysyl oxidase (LOX) and stiffen the cardiac...
JACC Specialty Journals
High-Sensitivity Cardiac Troponin T and I Discordance in Patients Receiving Immune Checkpoint Inhibitors | JACC: CardioOncology
Oct 20, 20265 minDr. David Austin discusses a JACC: CardioOncology study showing that high-sensitivity cardiac troponin T was elevated in 37.9% of patients starting immune checkpoint inhibitor (ICI) therapy, compared with only 1.8% for...
JACC Specialty Journals
Inflammatory Cell Profiles in Early- and Late-Manifestation Immune Checkpoint Inhibitor Myocarditis | JACC: CardioOncology
Oct 20, 20264 minDr. Cristina Gil-Cruz discusses a JACC: CardioOncology study comparing early- and late-manifestation immune checkpoint inhibitor (ICI) myocarditis, where endomyocardial biopsies showed greater T-cell and macrophage...
JACC Specialty Journals
Impact of Device Position and Aortic Valve Prolapse on Outcomes After Transcatheter VSD Closure | JACC: Asia
Oct 7, 20264 minCommentary by Dr. Timothy Un.
JACC Specialty Journals
Prognostic Impact of Residual Thrombus After Aspiration Thrombectomy in ST-Elevation Myocardial Infarction | JACC: Asia
Oct 7, 20264 minCommentary by Dr. Ziyad Ghazzal.
JACC Specialty Journals
Sex-Specific Lipid, Apolipoprotein B, and Lipoprotein(a) Responses to Berberine Based on 2 Randomized Placebo-Controlled Trials | JACC: Asia
Oct 7, 20263 minCommentary by Dr. Yihang Fan.
JACC Specialty Journals
Lifestyle and Metabolic Health, Low-Grade to Clinically Elevated Albuminuria, and Cardiovascular-Renal Diseases | JACC: Asia
Oct 7, 20264 minCommentary by Dr. Hongmei Yan.
JACC Specialty Journals
Efficacy and Safety of Quarterly Dosing SHR-1918 in Patients With Suboptimally Controlled Hyperlipidemia | JACC: Asia
Oct 7, 20265 minCommentary by Dr. Xiaojie Xie.
JACC Specialty Journals
Oncologic Benefits and Cardiovascular Risks of Pembrolizumab: Insights From a Nationwide Lung Adenocarcinoma Cohort | JACC: Asia
Oct 6, 20264 minCommentary by Dr. Koohyar Ahmadzadeh.
JACC Specialty Journals
Author Interview: Cholesterol Management Gaps Among Patients with Established Coronary Artery Disease Hospitalized for Acute Coronary Events | JACC: Advances
Oct 6, 202625 minDinesh Kalra, Todd Villines, and Lisandro Colantonio discuss the importance of this article, what encouraged Dr. Colantonio to conduct this research, and how clinicians can address the concerns patients have.
JACC Specialty Journals
Association of Implantation Depth with Hemodynamics and Mechanical Consequences in Small Valve-in-Valve TAVR | JACC: Asia
Oct 6, 20264 minCommentary by Dr. Shinichi Shirai
JACC Specialty Journals
Comparison of ASCVD Risk Prediction Models in STEMI: Insights from a South Asian Cohort | JACC: Asia
Oct 6, 20264 minCommentary by Dr. Justin Paul Gnanaraj
JACC Specialty Journals
Author Interview: Defining Clinically Meaningful Within-Patient Changes in Heart Failure | JACC: Heart Failure
Oct 2, 202626 minAkshay Desai and Amin Yehya discuss the newest JACC: Heart Failure Position Statement that proposes a pragmatic framework for defining clinically meaningful within-patient changes across heart failure outcomes to...
JACC Specialty Journals
Deep Dive Dialogue: Effect of Evolocumab on Grafts Post-Coronary Artery Bypass Surgery: Post-hoc Analysis of NEWTON-CABG CardioLink-5 | JACC: Advances
Oct 2, 202624 minDinesh Kalra, Andrew Choi, and G. B. John Mancini discuss the author group's post hoc analysis of the randomized NEWTON-CABG CardioLink-5 trial.
JACC Specialty Journals
Issue Summary: September 2026 | JACC: Advances
Sep 29, 20269 minAudio Summary of three articles from the September 2026 issue of JACC: Advances.
Recent guests
Recent guests on JACC Specialty Journals. Study who booked and why before you pitch.
D
David Austin
author and professor, British Board of Film Classification
M
Matt Martinez
Senior Engineering Geologist, SDC Broadcasting
M
Michael Wilkinson
Associate Professor of Medicine at University of California San Diego Health, Leadership Strategies
D
Dr. Michael Reardon
Professor and Chief of Cardiac Surgery, Catholic Schools Foundation
Best industries to pitch JACC Specialty Journals for
PitchCentric classifies JACC Specialty Journals under these industries. Guests from them are the closest fit, and each links to the best podcasts in that industry.
Similar Podcasts
Shows with the most semantically similar episode content. Pitch one, pitch all; producers cluster.
More on Professional & Technical Services
Guides and articles for guests pitching shows like this one.
Podcasts like JACC Specialty Journals
Is this podcast yours and you'd like to remove or correct details? Request removal or email privacy@pitchcentric.com.
Questions about the free trial? See the pricing FAQ